Tap to start →
Photo: Vitaly Gariev / Unsplash
1 / 6
Here's what the FDA label actually says.
2 / 6
Nausea hit 16% to 20% on Ozempic in trials, mostly during dose increases.
3 / 6
Pancreatitis, gallbladder and kidney problems. Know the warning signs.
4 / 6
Not for anyone with a history of medullary thyroid cancer or MEN 2.
5 / 6
Ozempic is for diabetes. Wegovy is the semaglutide approved for weight.
6 / 6
A real prescription from a licensed clinician and a licensed pharmacy.
Ozempic's safety profile from the FDA label: common side effects, serious warnings, who shouldn't use it, and why Wegovy is the weight-approved version.
Tap below for the full page. Not medical advice; talk to your clinician about your care.